LifeTech Scientific Corporation (HKG:1302)

Market Cap	6.81B
Revenue (ttm)	1.39B
Net Income (ttm)	236.66M
Shares Out	4.63B
EPS (ttm)	0.05
PE Ratio	27.20
Forward PE	15.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,832,000
Average Volume	23,221,921
Open	1.500
Previous Close	1.490
Day's Range	1.440 - 1.510
52-Week Range	1.240 - 2.070
Beta	1.23
RSI	48.57
Earnings Date	Mar 28, 2025

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,392
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1302

Financial Performance

In 2024, LifeTech Scientific's revenue was 1.30 billion, an increase of 2.88% compared to the previous year's 1.27 billion. Earnings were 222.39 million, a decrease of -15.52%.

Financial numbers in CNY